First-line Advanced Cutaneous Melanoma Treatments: Where Do We Stand?
Cutaneous melanoma has always been a dreaded diagnosis because of its high mortality rate and its proclivity for invasiveness and metastasis. Historically, advanced melanoma treatment has been limited to chemotherapy and nonspecific immunotherapy agents that display poor curative potentia...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
JMIR Publications
2021-12-01
|
| Series: | JMIR Cancer |
| Online Access: | https://cancer.jmir.org/2021/4/e29912 |